Assessment of SNPs associated with the human glucocorticoid receptor in primary open-angle glaucoma and steroid responders

Molecular Vision

Volumn 16, Issue , 2010, Pages 596-601

  Fingert, John H ^a   Alward, Wallace L ^a   Wang, Kai ^b   Yorio, Thomas ^c   Clark, Abbot F ^c  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF IOWA   (United States)

^c UNIVERSITY OF NORTH TEXAS HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EYE PROTEIN; GLUCOCORTICOID RECEPTOR; IMMUNOPHILIN; PROTEIN FKBP4; PROTEIN FKBP5; PROTEIN NR3C1; PROTEIN SFRS3; PROTEIN SFRS5; PROTEIN SFRS9; STEROID; UNCLASSIFIED DRUG; GLUCOCORTICOID;

ARTICLE; CONTROLLED STUDY; DRUG RESPONSE; FEMALE; GENE FREQUENCY; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC RISK; GENOTYPE; HUMAN; INTRAOCULAR HYPERTENSION; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; OPEN ANGLE GLAUCOMA; PATHOGENESIS; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GLAUCOMA, OPEN-ANGLE; GLUCOCORTICOIDS; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; RECEPTORS, GLUCOCORTICOID;

EID: 77952313436     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Budde WM. Heredity in primary open-angle glaucoma. Curr Opin Ophthalmol 2000; 11:101-6. [PMID: 10848214]
2. Wiggs JL. Genetic etiologies of glaucoma. Arch Ophthalmol 2007; 125:30-7. [PMID: 17210849]
3. Kwon YH, Fingert JH, Kuehn MH, Alward WL. Primary openangle glaucoma. N Engl J Med 2009; 360:1113-24. [PMID:19279343]
4. Gordon MO, Keltner JL, Miller JP, Parrish RK 2nd, Wilson MR, Kass MA. The Ocular Hypertension Treatment Study: baseline factors that predict the onset of primary open-angle glaucoma. Arch Ophthalmol 2002; 120:714-20. [PMID:12049575]
5. The AGIS Investigators. The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration. Am J Ophthalmol 2000; 130:429-40. [PMID: 11024415]
6. Lewis JM, Priddy T, Judd J, Gordon MO, Kass MA, Kolker AE, Becker B. Intraocular pressure response to topical dexamethasone as a predictor for the development of primary open-angle glaucoma. Am J Ophthalmol 1988; 106:607-12. [PMID: 3189477]
7. Kitazawa Y, Horie T. The prognosis of corticosteroidresponsive individuals. Arch Ophthalmol 1981; 99:819-23. [PMID: 7236083]
8. Becker B, Chevrette L. Topical corticosteroid testing in glaucoma siblings. Arch Ophthalmol 1966; 76:484-7. [PMID: 5928135]
9. Bartlett JD, Woolley TW, Adams CM. Identification of high intraocular pressure responders to topical ophthalmic corticosteroids. J Ocul Pharmacol 1993; 9:35-45. [PMID: 8463731]
10. Armaly MF. The heritable nature of dexamethasone-induced ocular hypertension. Arch Ophthalmol 1966; 75:32-5. [PMID: 5900502]
11. Rozsival P, Hampl R, Obenberger J, Starka L, Rehak S. Aqueous humour and plasma cortisol levels in glaucoma and cataract patients. Curr Eye Res 1981; 1:391-6. [PMID: 7318492]
12. McCarty GR, Schwartz B. Increased plasma noncortisol glucocorticoid activity in open-angle glaucoma. Invest Ophthalmol Vis Sci 1991; 32:1600-8. [PMID: 2016141]
13. Southren AL, Gordon GG, Weinstein BI. Genetic defect in cortisol metabolism in primary open angle glaucoma. Trans Assoc Am Physicians 1985; 98:361-9. [PMID: 3842204]
14. Duma D, Jewell CM, Cidlowski JA. Multiple glucocorticoid receptor isoforms and mechanisms of post-translational modification. J Steroid Biochem Mol Biol 2006; 102:11-21. [PMID: 17070034]
15. Bamberger CM, Bamberger AM, de Castro M, Chrousos GP. Glucocorticoid receptor beta, a potential endogenous inhibitor of glucocorticoid action in humans. J Clin Invest 1995; 95:2435-41. [PMID: 7769088]
16. Oakley RH, Sar M, Cidlowski JA. The human glucocorticoid receptor beta isoform. Expression, biochemical properties, and putative function. J Biol Chem 1996; 271:9550-9. [PMID: 8621628]
17. Goecke A, Guerrero J. Glucocorticoid receptor beta in acute and chronic inflammatory conditions: clinical implications. Immunobiology 2006; 211:85-96. [PMID: 16446173]
18. Lewis-Tuffin LJ, Cidlowski JA. The physiology of human glucocorticoid receptor beta (hGRbeta) and glucocorticoid resistance. Ann N Y Acad Sci 2006; 1069:1-9. [PMID: 16855130]
19. Zhang X, Clark AF, Yorio T. Regulation of glucocorticoid responsiveness in glaucomatous trabecular meshwork cells by glucocorticoid receptor-beta. Invest Ophthalmol Vis Sci 2005; 46:4607-16. [PMID: 16303956]
20. Chen M, Manley JL. Mechanisms of alternative splicing regulation: Insights from molecular and genomics approaches. Nat Rev Mol Cell Biol 2009; 10:741-54. [PMID 19773805]
21. Xu Q, Leung DY, Kisich KO. Serine-arginine-rich protein p30 directs alternative splicing of glucocorticoid receptor premRNA to glucocorticoid receptor beta in neutrophils. J Biol Chem 2003; 278:27112-8. [PMID: 12738786]
22. Yan XB, Tang CH, Huang Y, Fang H, Yu ZQ, Wu LM, Liu RY. Alternative splicing in exon 9 of glucocorticoid receptor premRNA is regulated by SRp40. Mol Biol Rep 2010; 37:1427-33. [PMID: 19343537]
23. Zhang X, Clark AF, Yorio T. FK506-binding protein 51 regulates nuclear transport of the glucocorticoid receptor beta and glucocorticoid responsiveness. Invest Ophthalmol Vis Sci 2008; 49:1037-47. [PMID: 18326728]
24. Thorleifsson G, Magnusson KP, Sulem P, Walters GB, Gudbjartsson DF, Stefansson H, Jonsson T, Jonasdottir A, Jonasdottir A, Stefansdottir G, Masson G, Hardarson GA, Petursson H, Arnarsson A, Motallebipour M, Wallerman O, Wadelius C, Gulcher JR, Thorsteinsdottir U, Kong A, Jonasson F, Stefansson K. Common sequence variants in the LOXL1 gene confer susceptibility to exfoliation glaucoma. Science 2007; 317:1397-400. [PMID: 17690259]
25. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS, Haynes C, Henning AK, SanGiovanni JP, Mane SM, Mayne ST, Bracken MB, Ferris FL, Ott J, Barnstable C, Hoh J. Complement factor H polymorphism in age-related macular degeneration. Science 2005; 308:385-9. [PMID: 15761122]
26. Manolio TA, Collins FS, Cox NJ, Goldstein DB, Hindorff LA, Hunter DJ, McCarthy MI, Ramos EM, Cardon LR, Chakravarti A, Cho JH, Guttmacher AE, Kong A, Kruglyak L, Mardis E, Rotimi CN, Slatkin M, Valle D, Whittemore AS, Boehnke M, Clark AG, Eichler EE, Gibson G, Haines JL, Mackay TF, McCarroll SA, Visscher PM. Finding the missing heritability of complex diseases. Nature 2009; 461:747-53. [PMID: 19812666]
27. Gordon MO, Kass MA. The Ocular Hypertension Treatment Study: design and baseline description of the participants. Arch Ophthalmol 1999; 117:573-83. [PMID: 10326953]
28. Collaborative Normal-Tension Glaucoma Study Group. Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures. Am J Ophthalmol 1998; 126:487-97. [PMID: 9780093]
29. Han B, Kang HM, Seo MS, Zaitlen N, Eskin E. Efficient association study design via power-optimized tag SNP selection. Ann Hum Genet 2008; 72:834-47. [PMID: 18702637]
30. Clark AF, Morrison JC. Steroid-induced glaucoma. In: Morrison JC, Pollack IP, editors. Glaucoma: Science and Practice. New York: Thieme; 2003. p. 197-206.
31. Stokes J, Walker BR, Campbell JC, Seckl JR, O'Brien C, Andrew R. Altered peripheral sensitivity to glucocorticoids in primary open-angle glaucoma. Invest Ophthalmol Vis Sci 2003; 44:5163-7. [PMID: 14638712]
32. Zhang X, Ognibene CM, Clark AF, Yorio T. Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta. Exp Eye Res 2007; 84:275-84. [PMID: 17126833]
33. Gerzenstein SM, Pletcher MT, Cervino AC, Tsinoremas NF, Young B, Puliafito CA, Fini ME, Schwartz SG. Glucocorticoid receptor polymorphisms and intraocular pressure response to intravitreal triamcinolone acetonide. Ophthalmic Genet 2008; 29:166-70. [PMID: 19005987]